Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID
· Real-Time Price · USD
1.84
0.20 (12.20%)
At close: Oct 03, 2025, 3:59 PM
1.82
-1.09%
Pre-market: Oct 06, 2025, 06:29 AM EDT
13F Institute Ownership
Total Institutes of 70 in Ovid Therapeutics reduced their positions with a decrease of 12 investors compared to the previous quarter. A reduction of 2.9M shares, as total invested capital declined by $258.91K with ownership percentage increasing from 31.09% to 2877.10%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Co Ltd | 602.56% | 7.53M | +0.00% | 2.49M | 12.71% | Aug 08, 2025 |
| Bvf Inc/il | 308.31% | 3.85M | +0.00% | 1.27M | 0.05% | Aug 14, 2025 |
| Vanguard Group Inc | 210.89% | 2.64M | -15.2% | 869.92K | < 0.01% | Aug 11, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.